INDRAPRASTHA MEDICAL CORP.LTD. - Board Meeting Outcome for Approval Of Audited Financial Results & Recommendation Of Dividend For The Financial Year 2023-24

The Board of Directors of the Company at its meeting held on 17th May, 2024 i.e. today, interalia: 1. Approved audited financial statements for the year ended 31st March, 2024; and 2. Recommended a dividend @45% i.e. Rs. 4.50 per share for the financial year 2023-24. Details are given in the enclosed letter.